Market Tracker

07/22 10:52am ET

Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.05
Data as of 10:36am ET
 +0.01 / +0.96%
Today’s Change
0.78
Today|||52-Week Range
1.50
-9.48%
Year-to-Date
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close1.04
Today’s open1.05
Day’s range1.03 - 1.07
Volume83,331
Average volume (3 months)559,518
Market cap$45.4M
Dividend yield--
Data as of 10:36am ET, 07/22/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-241.48%
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-19.03%
P/E ratio2.0
Price/Sales1.47
Price/Book8.64

Competitors

 Today’s
change
Today’s
% change
REPHRecro Pharma Inc+0.02+0.33%
MNOVMediciNova Inc+0.00+0.01%
OPXAOpexa Therapeutics I...0.000.00%
CDXICardax Inc+0.02+3.11%
Data as of 10:36am ET, 07/22/2014

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$34.5M
Annual profit (last year)$18.2M
Net profit margin52.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Operating Officer
George W. Hebard
Chief Financial Officer &
Vice President-Finance
Richard L. Feinstein
Corporate headquarters
Piscataway, New Jersey

Forecasts